- Home
- LPSN vs XGN Comparison
LPSN vs XGN Comparison
Compare LPSN & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- XGN
- Stock Information
- Founded
- LPSN 1995
- XGN 2002
- Country
- LPSN United States
- XGN United States
- Employees
- LPSN N/A
- XGN N/A
- Industry
- LPSN EDP Services
- XGN Medical Specialities
- Sector
- LPSN Technology
- XGN Health Care
- Exchange
- LPSN Nasdaq
- XGN Nasdaq
- Market Cap
- LPSN 81.6M
- XGN 69.4M
- IPO Year
- LPSN 2000
- XGN 2019
- Fundamental
- Price
- LPSN $0.95
- XGN $3.91
- Analyst Decision
- LPSN Hold
- XGN Strong Buy
- Analyst Count
- LPSN 5
- XGN 2
- Target Price
- LPSN $0.98
- XGN $7.50
- AVG Volume (30 Days)
- LPSN 1.3M
- XGN 93.5K
- Earning Date
- LPSN 03-05-2025
- XGN 03-11-2025
- Dividend Yield
- LPSN N/A
- XGN N/A
- EPS Growth
- LPSN N/A
- XGN N/A
- EPS
- LPSN N/A
- XGN N/A
- Revenue
- LPSN $312,474,000.00
- XGN $55,641,000.00
- Revenue This Year
- LPSN N/A
- XGN $20.54
- Revenue Next Year
- LPSN $1.72
- XGN $11.86
- P/E Ratio
- LPSN N/A
- XGN N/A
- Revenue Growth
- LPSN N/A
- XGN 5.89
- 52 Week Low
- LPSN $0.45
- XGN $1.30
- 52 Week High
- LPSN $2.08
- XGN $6.22
- Technical
- Relative Strength Index (RSI)
- LPSN 41.60
- XGN 59.91
- Support Level
- LPSN $0.84
- XGN $3.41
- Resistance Level
- LPSN $1.09
- XGN $4.19
- Average True Range (ATR)
- LPSN 0.07
- XGN 0.45
- MACD
- LPSN 0.01
- XGN 0.11
- Stochastic Oscillator
- LPSN 36.52
- XGN 90.14
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation.. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.